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Sum m ary
We have compared the efficacy of local UVB photother­
apy with topical (bath) photochemotherapy in 13 patients 
with bilateral chronic hand dermatitis. In each patient, 
one hand was treated with UVB phototherapy and the 
other hand with topical (bath) photochemotherapy. Both 
treatments moderately improved the chronic hand der­
matitis after 6 weeks’ treatment. We observed no signifi­
cant differences in improvement between the modalities, 
but side-effects occurred more often on the photoche- 
motherapy-treated side. Considering the similar 
responses and relative incidence of side-effects, we 
would advise starting treatment with UVB phototherapy 
and only using topical photochemotherapy if this fails.
Several studies have shown the therapeutic effectiveness 
of oral psoralen photochemotherapy (PUVA) in treating 
hand dermatitis, defined as a chronic inflammatory 
eruption of the hands with vesicles or hyperkeratotic 
lesions without evidence of psoriasis. The efficacy of 
UVB phototherapy has also been demonstrated in 10 
patients with allergic contact dermatitis of the hands; 
treatment times, however, were lengthy (the mean being 
5 months) and maintenance therapy was necessary. In a 
further study, oral PUVA was compared with UVB 
phototherapy in 35 patients with chronic eczematous 
dermatitis of the hands of varying aetiology, both treat­
ments being effective, although the results with PUVA 
were better. Finally, topical PUVA for chronic hand and 
foot dermatoses has also been shown to be effective, 
while topical (bath) PUVA in psoriasis was as useful as 
oral PUVA;8,9 in addition, an advantage of the topical 
over oral PUVA was the lack of systemic, particularly 
gastrointestinal, side-effects.
Phototherapy increases the incidence of phototoxic 
reactions and non-melanoma skin cancer, but the risk
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PUVA.11 Topical PUVA also carries this risk but it is not 
known whether this differs from that of oral PUVA; it has, 
however, been suggested that topical treatment may be 
safer.1 ’13 Nevertheless, in view of the probable greater 
safety of UVB phototherapy, we have carried out a left- 
right comparison of its therapeutic efficacy as compared 
with that of topical bath PUVA in chronic hand dermatitis.
Patients
Thirteen patients with bilateral chronic hand dermatitis 
entered the study after informed consent was obtained, 
the disorder being defined as an eruption with vesicles or 
hyperkeratotic plaques of the hands present for longer 
than 6 months. Patients with severe vesiculation or bullae 
or with evidence of psoriasis were excluded. Photo­
dermatoses, light-aggravated dermatoses, and a history 
of melanoma, immunosuppressive therapy, severe impair­
ment of renal or liver function or pregnancy were reasons 
for exclusion.
In all patients, cutaneous patch testing was first under­
taken with the European standard series following Inter­
national Contact Dermatitis Research Group (ICDRG) 
guidelines; intracutaneous skin tests were also performed 
with a standard tray (Bencard, Artu Biologicals, Lelystad, 
The Netherlands).
Methods
Each patient was treated with local UVB phototherapy on 
one hand and topical (bath) PUVA on the other, alternate 
patients being selected for UVB phototherapy for the 
right hand and topical PUVA for the left and vice versa. 
UVB phototherapy was carried out three times a week 
and topical PUVA treatment twice. All patients were 
treated for 6 weeks with the exception of one patient who 
cleared after 3 weeks. At the end of the 6 weeks, we 
continued the therapy with both modalities if a compar­
able clinically significant improvement was obtained,
© 1997 Blackwell Science Ltd 7
8 SIMONS, I.J.W.E.BOHNEN AND P.G.M DER VALK
Mean total score ±  s.o.m. 
Before treatment
;r treatment
Mean number of 
treatments (range)
Mean maximum ultraviolet 
dose (range), J/cm"
Mean total ultraviolet dose 
(range), J /em 2
mi r il» , «fvi*
UVB-trcated side
—44 •«--- I I '* »
8-98 ±2-17  
5-51 ±2-14
17 (6-19)
0-8 (0-1-1-0)
5-7 (0*5—7-2)
Bath PUVA-treated side
10-17 ±  2-26 
7-66 ±  2-58
11 (4-13)
1-3 (0*3—2*0)
7-1 (1-0—10*7)
Tabic 1. Improvement of bilateral hand 
dermatitis after 6 weeks o f treatment with 
topical UVB to one hand and topical bath
PU VA to the other (ii U )
stopped it completely if no improvement had occurred, 
and treated both with the more effective of either UVB
a
3
of 0 -4
51-75% , 4
2 26-50% ,
area we
phototherapy or topical PUVA if a clinically greater scored the intensity of erythema and oedema, vesicles 
improvement had occurred with one of the modalities, and papules, and dryness, scaling and hyperkeratosis, on
From 1 week before the start until the end of the study a 0—3 scale none, 1 irate,
the participants were not allowed to use any medication 3 severe). Finally, for each area we multiplied together
other than bland emollients for the hands, and all were the percentage of the affected area, the correction factor 
instructed to avoid contact with water and irritants and to and the sum of the intensities of the symptoms, after
which the total score was the sum of the scores of theavoid relevant allergens where possible.
Clinical evaluation
seven areas. We also independently evaluated the sub­
jective complaints o f itching and pain on a 0 -3  scale. 
Before the start of the study we assessed the minimal
At the start of treatment and at 2-weekly intervals, the erythema dose (MED) and the minimal phototoxic dose
hands were evaluated by means of a clinical assessment (MPD) on the ventral side of the forearm in 10 healthy
score, based on a severity index corrected for the size of volunteers; the mean M ED was 54 s (0*18J/cm 2) and
the affected skin area. For this, we divided each hand into 80 s (0162 J /cm “), respectively. We then started treatment
seven areas, the palm, the back of the hand and the five with 40% of the mean M ED or MPD. The incremental
fingers, each area having its own correction factor based dose at each treatment was 20% for topical PUVA, while
on the relative size of this skin area, estimated for the for UVB we started with 20% increments for the first five
palm and back of the hand as 0-25 and for the fingers 01; treatments and then slowly tapered the incremental
the percentage of the area affected was then indicated on if slight erythema occurred, however, the dose was not
Table 2. Individual improvement of bilateral hand dermatitis alter 6 
weeks’ treatment.
increased, while if  there was moderate ery thema the 
was decreased
treatment was
and lì severe erythema, no 
one session and the
decreased by 50% at the next.
Patient
UVB-trcated side 
(% improvement)
Bath PUVA-treated side
(% improvement)
1 100 100
2 14 -1 1
3 -1 0 0 0
4 21 - 7
5 3 3
6 11 39
7 53 66
8 1 39
9 76 66
10 55 - 2 6
11 80 45
12 64 70
13 56 53
U VB treatment
The UVB light source consisted of a Waldmann U V 200 
unit (14 F8T5 UVB tubes) above a Waldmann UV 180 
unit (eight F15T8 UVB tubes), the emission spectrum 
being 285—350 nm with peaks at 310 and 315 nm, and the
m *^
intensity 2,9 -3 -6m W /cm ‘\
PUVA treatment
immer
solution of the psoralen, trioxsalen, for 15min, 8 ml of 
trioxsalen at a concentration of 0* 1 m g/m l being diluted 
in 41 of water. Immediately afterwards, exposure to U VA 
took place in a Waldmann PUVA 200 unit H4 Svlvania
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F8T5 PUVA tubes) above a Waldmannn PUVA 180 unit the UVB-treated side and 10*17 on the PUVA side, while
(five F15T8 PUVA and three TL-09 Philips afterwards it was 5-51 on the UVB side and 7-66 on the
tubes), the emission spectrum being 315-400nm and PUVA side; this corresponds to a 39 in
intensity 7-2—8-2m W /cm i'. score for the UVB side (P < 0*05) and 25% for the
With both methods, the hands were put into the light PUVA side (P < 0*05). This difference in 
unit with the palmar surface downwards resting on the was not statistically significant (P > 0-05).
glass plate of the 200 unit. Individually, the reductions in score var from
to ) for UVB and from -26%  to 100%)
S  ta tisi ica I m et h o ds
Both PUVA and
of one-ts
compare
efficacies were evaluated by means 
’s /-test for paired samples to
e treatment and at 6
for PUVA, the minus sign denoting deterioration (see 
Table 2) while the mean number of treatments for UVB 
was 17 and for PUVA 11, the mean total dose of UVB 
being 5-7 J /cm 2 and of UVA 7-1 J /cm 2.
weeks. To compare the relative UVB and PUVA treatment
two-tailed t-test • pairea samples.
All 13 patients suffered from different degrees of itching 
on both hands; after 6 weeks, however, six were free of 
the discomfort on both sides and three remarkably betterVr
There were seven male and six female patients with hand on the UVB side, while in four there was no change. We 
dermatitis of the palms and the fingers with mean age 47 noted no marked change in pain, however, nine patients 
years 5 months. The mean duration of the dermatitis was initially complaining of this in both hands and eight still 
5 years 8 months; in all patients it was of the chronic type complaining of it after 6 weeks.
not f to topical treatment or avoidance of At the end of the 6 weeks, treatment was continued in
allergic or irritant contact factors. In 12 patients, vesicles nine of the patients. Three received PUVA to both hands, 
were observed during the course of the disease. Five with improvement but not total clearance in two, though 
patients showed positive cutaneous patch tests, there this was slow on the side previously treated with UVB,
being positive reactions to chromate and cobalt in one while in two others UVB was continued to both hands for
and just chromate in another; a further one showed 6 and 11 further weeks, respectively; slight to moderate
positive reactions to monothioglycollate and thioglycollic improvement was achieved on the side initially treated
one to primin, and one PUVA, while in one patient the hand that had
multiple positive reactions to thiuram, formaldehyde, received UVB from the beginning became almost totally
quarternium 15, iodine tincture, benzoyl peroxide and 
diazolidinylurea. Nine of 
atopic
bv 12 Thi*ee patients were
a
¡ease and 10 showed one or more
PUVA on one side and UVB on the other for 8 -14  
weeks; two showed improvement in both
intracutaneous skin tests. At the time of inclusion in the more on the PUVA side, while in the 
study, however, none of these positive tests were appar- were almost clear after 12 weeks, 
ently relevant to the eczema, although in nine patients, 
irritant factors probably played a significant part. Three
Si de-effects
During the 6-week observation period, two patients
UV radiation-induced erythema of the
patients were of skin type II, seven skin type III and three 
skin type IV as defined by Fitzpatrick.1'*
Twelve patients were treated with UVB and PUVA for 
at least 6 weeks. One cleared completely after 3 weeks of UVB-treated side on a total of three occasions, while
and was still clear after 6 weeks; in this six suffered phototoxic reactions from PU VA on a total of 
case, we used the clinical score at 3 weeks as the score for nine occasions; skin type did not seem relevant to the
s. In ;6 weeks. Pour patients discontinued therapy because of a development of 
lack of significant improvement after 6 weeks, and we treated side became for more pigmented than the UVB. 
chose to continue PUVA for both hands in three other 
cases and U VB in two; in three, however, there was no 
significant difference between the therapies and in these
we continued UVB for one hand and PUVA for the other. We cannot conclude that or
PUVA treatment of chronic hand dermatitis has higher
Comparison o f  the U VB and P U V 4 treatment ejficacies 
The results after 6
efficacy than the other, the higher mean percentage of
in the total severity scores after local♦*
treatment are listed in (39%) compared with topical bath PUVA (25%) after 6 
Table 1, the mean total score before being 8*98 on weeks of treatment not being statistically significant.
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Thus the improvement in derm atitis follow ing 2. Mobacken I I, Rosen K, Swanbcck G. Oral psoralen photoche
phototherapy in this study both in terms of reductions 
in clinical scores and in patient satisfaction was limited, 
in contrast to the findings in other studies. Patient 
selection and an abrupt cessation of topical corticoster-
motherapv (PUVA) of hyperkeratotic dermatitis of the palms. Br 
J  Dermatol 1983; 109: 205-8.
3. Morison WL, Parrish JA, Fitzpatrick TB. Oral methoxalen 
pholochemotherapv of recalcitrant dermatoses of the palms and
soles. Br J  Dermatol 1978; 99: 297-302.
oid  and tar therapy m ay  be on e  exp lan ation , w h ile  4. Tcgner E, Thelin I. PUVA treatment of chronic eczematous
another may be differences in the UVB and PUVA 
dosage regimens.
Topical bath PUVA led to burning reactions more 
often than UVB, these often tending to occur unexpect-
dermatitis of the palms and soles. Acta Derm Venereal (Stockh)
; 65: 451-3.
5. Mork N-j, Austad J. Short-wave ultraviolet light (UVB) treat­
ment of allergic contact dermatitis of the hands. A da  Derm
Venercol (Stockh) 1983; 63: 87-9.
G. Chronic eczematous 
dermatitis of the hands: a comparison of PUVA and UVB 
treatment. Acta Derm lenereol (Stockh) 1987; 67: 48-54.
7. Hawk JLM, Le Grice P. The efficacy of localized PU VA therapy 
for chronic hand and foot dermatoses. Clin Dermatol 1994; 19:
479-82.
way. Further, taking into account this high incidence of 8. Viiatainen N, Ilannukela M, Karoncn J. Long-term local trioxsa-
edly, necessitating large reductions in dose; interestingly 6- Rosen K, Mobacken 
no relationship with skin type was found. This high 
incidence of phototoxic reactions with topical PUVA has 
also been observed by other investigators,9 and we advise 
great care with dose increments in patients treated this
o fphototoxic reactions and the possible 
premalignant and malignant skin lesions following topi­
cal bath PUVA therapy, we consider it advisable to start 
with local UVB treatment for chronic eczematous der-
len photochemotherapy in psoriasis. Dermatologica 1981; 163:
229-31.
9. Lowe NJ, Weingarten D, Bourget T, Moy LS. PUVA therapy for 
psoriasis; comparison of oral and bath-water delivery of 8
methoxy psoralen. J  Am Acati Dermatol 1986; 14: 754-60. 
matitis of the hands, particularly as such therapy is also K). Murray D, Corbett MF, Warin AP. A controlled trial of photo
less time consuming, no bath being required and sun- 
protection of the hands not being needed after the 
treatment sessions. If there is no therapeutic effect with 
the UVB, however, topical bath PUVA might then be 
considered. Further work is necessary to define more 
precisely the benefits of phototherapy as a supplement to 
topical treatment in this distressing condition.
References
1. LeVinc MJ, Parrish JA, Fitzpatrick TB. Oral
photochemotherapv (PUVA) of dyshidrotic eczema. Acta Derm
Venereal (Stockh) 1*981; 61: 570-1.
chemotherapy for persistent palmoplantar pustulosis. Br J Der­
matol 1980; 102: 659-63.
11. Slapcr H, Schothorst AA, van der Leun JC. Risk evaluation of 
UVB therapy for psoriasis: comparison of calculated risk for UVB 
and observed risk in PUVA-treated patients. Photodennatoloiry
1986; 3: 271-83.
12. Lindelof B, Sigurgeirsson B, Tegner E et al. Comparison of the 
carcinogenic potential o f  trioxsalen bath PUVA and oral meth- 
oxsalen PUVA: a preliminary report. Arch Dermatol 1992; 128:
1341-4.
13. Berne B, Fischer T, Michaelsson G, Noren P. Long-term safety of 
trioxsalen bath PUVA treatment: an 8-year follow-up of 149
patients. P/ioto(lermutvlojry\l)84; I: 18-22.
14. Fitzpatrick TB. Soleil et neau. 7 Med Esthvt 1975; 2: 33 4.
€) 1997 Blackwell .Science Ltd, ('Jinica! and lixpcnnicntal DcrmtUolnuy, 22, 7 1(1
